Omnicell Inc is a healthcare technology company that specializes in streamlining medication management and supply chain solutions for pharmacies and healthcare facilities
The company develops automated systems and software that enhance the efficiency of medication dispensing, inventory management, and patient safety. By offering a comprehensive suite of products, including automated dispensing cabinets, central pharmacy automation, and cloud-based analytics, Omnicell aims to improve the operational workflows of healthcare providers, reduce medication errors, and ultimately enhance patient care. Their innovative solutions are designed to meet the evolving needs of the healthcare industry, supporting successful medication therapies and optimizing pharmacy operations.
Healthcare tech company Omnicell (NASDAQOMCL) reported Q4 CY2024 results topping the market’s revenue expectations, with sales up 18.6% year on year to $306.9 million. On the other hand, next quarter’s revenue guidance of $260 million was less impressive, coming in 2% below analysts’ estimates. Its non-GAAP profit of $0.60 per share was 2.8% above analysts’ consensus estimates.
Companies Reporting Before The Bell • Ares Management (NYSEARES) is expected to report quarterly earnings at $1.09 per share on revenue of $864.54 million.
